Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bromfenac vs Dexamethasone for inflammation after cataract surgery
NCT03317847Phase 4Completed
- Sponsor
- Azienda USL-IRCCS di Reggio Emilia
- Start
- Oct 2017
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bromfenac sodium in post-operative ocular inflammation, sponsored by Azienda USL-IRCCS di Reggio Emilia. Started Oct 2017; status: completed.
02
Drugs
bromfenac sodium
03
Conditions
post-operative ocular inflammation
Beyond the preview
Go deeper on NCT03317847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03317847.